Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma

Clinical trial NCT06198465 · UNKNOWN

Trial details

NCT number: NCT06198465
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adebrelimab Esophageal Cancer Perioperative Period

Start date: 2024-03-30
Primary completion: 2024-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.